Which sedative is safer for laser scar therapy? new study aims to find out
NCT ID NCT07213544
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two sedatives, remimazolam and propofol, given during laser treatment for burn scars. The goal is to see which drug causes fewer breathing problems. About 136 adults will take part, each receiving both drugs in separate sessions. The results could help doctors choose a safer option for similar procedures.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Remimazolam besylate and Propofol
What this could lead to
If one drug proves safer, it could become the preferred sedative for short laser procedures, reducing breathing complications.
What could go wrong
This is a small, early-phase study (136 people) comparing two already-approved drugs, so it won't produce a new treatment. Results may not apply to longer or different procedures.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BURN SCAR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Medical University of South Carolina
RECRUITINGCharleston, South Carolina, 29425, United States
Contact